Note dell’episodio
Episode 155 — 31 October 2026
Examining FDA's RWE guidance for post-marketing studies, CMS's new hospital value model, ISPOR's digital therapeutics framework, and EMA's AI reflection paper.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast

